KALA BIO, INC. Earnings Per Share (Basic)
KALA BIO, INC. (KALA) reported Earnings Per Share (Basic) of -$21.32 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-19
- KALA BIO, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$21.32.
- KALA BIO, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.14.
- KALA BIO, INC. earnings per share, basic for the quarter ending 2025-12-31 was $0.05.
- KALA BIO, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$1.07.
- KALA BIO, INC. earnings per share, basic for fiscal 2025 was -$3.31.
- KALA BIO, INC. earnings per share, basic for fiscal 2024 was -$10.15.
- KALA BIO, INC. earnings per share, basic for fiscal 2023 was -$17.35.
- KALA BIO, INC. earnings per share, basic for fiscal 2022 was -$29.48.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$21.32 10-Q · filed 2026-08-19 | -$0.21 10-Q · filed 2026-08-19 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$1.27 derived: net income ÷ weighted average shares · filed 2026-08-19 | |||
| 2026-03-31 | -$0.14 10-Q · filed 2026-05-15 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$2.48 derived: net income ÷ weighted average shares · filed 2026-08-19 | |||
| 2025-12-31 | $0.05 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.70 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$2.72 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$3.31 10-K · filed 2026-04-15 | |||
| 2025-09-30 | -$1.07 10-Q · filed 2025-11-19 | -$5.22 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$4.17 10-Q · filed 2025-11-19 | -$11.95 derived: net income ÷ weighted average shares · filed 2026-08-19 | |||
| 2025-06-30 | -$85.64 10-Q · filed 2026-08-19 | -$1.71 10-Q · filed 2025-08-08 | -$156.32 10-Q · filed 2026-08-19 | -$3.13 10-Q · filed 2025-08-08 | -$17.11 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$15.53 derived: net income ÷ weighted average shares · filed 2026-08-19 | |
| 2025-03-31 | -$70.49 10-Q · filed 2026-05-15 | -$1.41 10-Q · filed 2025-05-14 | -$7.09 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$8.27 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$11.42 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||
| 2024-12-31 | -$1.74 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$3.67 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$6.48 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$10.15 10-K · filed 2026-04-15 | |||
| 2024-09-30 | -$1.93 10-Q · filed 2025-11-19 | -$4.84 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$8.68 10-Q · filed 2025-11-19 | -$11.82 derived: net income ÷ weighted average shares · filed 2025-11-19 | |||
| 2024-06-30 | -$3.16 10-Q · filed 2025-08-08 | -$7.32 10-Q · filed 2025-08-08 | -$10.52 derived: net income ÷ weighted average shares · filed 2025-08-08 | -$13.94 derived: net income ÷ weighted average shares · filed 2025-08-08 | |||
| 2024-03-31 | -$4.20 10-Q · filed 2025-05-14 | -$7.39 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$10.82 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$15.11 derived: net income ÷ weighted average shares · filed 2025-05-14 | |||
| 2023-12-31 | -$3.18 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$6.58 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$10.87 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$17.35 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$3.41 10-Q · filed 2024-11-12 | -$7.74 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$14.36 10-Q · filed 2024-11-12 | -$21.54 derived: net income ÷ weighted average shares · filed 2024-11-12 | |||
| 2023-06-30 | -$4.36 10-Q · filed 2024-08-06 | -$11.15 10-Q · filed 2024-08-06 | -$18.64 derived: net income ÷ weighted average shares · filed 2024-08-06 | -$4.57 derived: net income ÷ weighted average shares · filed 2024-08-06 | |||
| 2023-03-31 | -$6.99 10-Q · filed 2024-05-14 | -$14.83 derived: net income ÷ weighted average shares · filed 2024-05-14 | $1.03 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$15.80 derived: net income ÷ weighted average shares · filed 2024-05-14 | |||
| 2022-12-31 | -$7.97 derived: net income ÷ weighted average shares · filed 2024-03-29 | $10.43 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$7.75 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$29.48 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $19.39 10-Q · filed 2023-11-13 | $0.64 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$21.46 10-Q · filed 2023-11-13 | -$54.18 derived: net income ÷ weighted average shares · filed 2023-11-13 | |||
| 2022-06-30 | -$18.92 10-Q · filed 2023-08-04 | -$0.38 10-Q · filed 2022-08-11 | -$41.10 10-Q · filed 2023-08-04 | -$0.83 10-Q · filed 2022-08-11 | -$74.50 derived: net income ÷ weighted average shares · filed 2023-08-04 | -$96.18 derived: net income ÷ weighted average shares · filed 2023-08-04 | |
| 2022-03-31 | -$22.18 10-Q · filed 2023-05-09 | -$0.45 10-Q · filed 2022-05-16 | -$55.76 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$77.57 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$8.44 derived: net income ÷ weighted average shares · filed 2023-05-09 | ||
| 2021-12-31 | -$33.91 derived: net income ÷ weighted average shares · filed 2023-03-03 | -$55.74 derived: net income ÷ weighted average shares · filed 2023-03-03 | -$5.00 derived: net income ÷ weighted average shares · filed 2023-03-03 | -$108.32 10-K · filed 2023-03-03 | -$2.19 10-K · filed 2022-03-29 | ||
| 2021-09-30 | -$21.41 10-Q · filed 2022-11-08 | -$1.96 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$73.80 10-Q · filed 2022-11-08 | ||||
| 2021-06-30 | -$0.57 10-Q · filed 2022-08-11 | -$1.06 10-Q · filed 2022-08-11 | |||||
| 2021-03-31 | -$0.49 10-Q · filed 2022-05-16 | ||||||
| 2020-12-31 | -$1.99 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |